⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

SGMO News

Sangamo Therapeutics, Inc. Common Stock

Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2025 Financial Results